---
layout: post
title: "864 hz - Rife Frequency"
description: "Comprehensive guide to 864 Hz Rife frequency: universal foundational master frequency for ALS motor neuron support, Alzheimer's cognitive restoration, tertiary Lyme disease, and Mycoplasma fermentans."
subject: "864 hz - Rife Frequency"
apple-title: "864 hz - Rife Frequency"
app-name: "864 hz - Rife Frequency"
tweet-title: "864 hz - Rife Frequency"
tweet-description: "Comprehensive guide to 864 Hz Rife frequency: universal foundational master frequency for ALS motor neuron support, Alzheimer's cognitive restoration, tertiary Lyme disease, and Mycoplasma fermentans."
date: 2024-11-22
keywords: "frequency benefits, Brain Beats, Frequencies, brainwave entrainment, sound therapy, 864 hz, rife frequency, universal neuro-supportive master frequency, als amyotrophic lateral sclerosis, alzheimers disease, lyme disease tertiary, mycoplasma fermentans, crane frequency, CAFL master frequencies"
---

The **864 Hz Rife Frequency** is universally recognized as one of the most vital neuro-supportive, antineurodegenerative, and antimicrobial master frequencies in the Consolidated Annotated Frequency List (CAFL) and historic Crane/Rife clinical protocols. Positioned at approximately **A5 (+28.3 cents)** in the fifth musical octave, 864 Hz is revered as the **Motor Neuron, Cognitive Harmonization, and Chronic Neuroborreliosis Master Anchor**.

Cataloged across numerous clinical protocols, 864 Hz is calibrated to provide structural and electro-acoustic stabilization in **Amyotrophic Lateral Sclerosis (ALS Stages 1 & 5)**, support memory circuits and amyloid clearance in **Alzheimer's Disease (Alzheimers TR)**, eradicate deep neural biofilms in **Tertiary Lyme Disease (Lyme 1, 2 & tertiary)**, suppress **Mycoplasma fermentans**, and neutralize systemic respiratory viral complexes.

In electro-acoustic medicine, 864 Hz exerts a protective vibrational influence across the anterior horn of the spinal cord, cortical pyramidal neurons, and blood-brain barrier micro-vessels, down-regulating excitotoxic glutamate accumulation and promoting neurotrophic factor synthesis.

---

### Core Biophysical Indications & Target Applications

The 864 Hz master frequency preset covers an extensive clinical and neuro-supportive scope:

- **Primary Pathological Targets:** *Amyotrophic Lateral Sclerosis* (ALS stages 1 & 5, fasciculations, bulbar weakness), *Alzheimer's Disease* (neurofibrillary tangles, amyloid beta plaques, cognitive decline), *Borrelia burgdorferi* (late-stage tertiary neuroborreliosis, chronic encephalopathy), *Mycoplasma fermentans* (incognitus strain), and respiratory viral complexes.
- **Biophysical Resonance Mechanisms:** Resonant desynchronization of excitotoxic motor neuron NMDA receptor hyperactivation; stimulation of brain-derived neurotrophic factor ($BDNF$) and glial cell line-derived neurotrophic factor ($GDNF$); mechanical disruption of spirochetal cystic and biofilm forms; acoustic destabilization of wall-less *Mycoplasma* lipid membranes; enhancement of cerebral glymphatic waste drainage.
- **Primary Delivery Modalities:** High-precision Pure Sine Wave Synthesis, Bilateral Stereo Binaural Entrainment, Whole-Body Vibroacoustic Sound Tables, and Cranial/Spinal Acoustic Transducers.

```
+-------------------------------------------------------------------------+
|                    864 Hz ACOUSTIC HARMONIC STRUCTURE                   |
+-------------------------------------------------------------------------+
|  Sub-octaves:     216.00 <---> 432.00                                   |
|  Fundamental:     864.00 Hz  (A5 (+28.3 cents))                         |
|  Overtones:       1728.00 <---> 2592.00 <---> 3456.00                   |
+-------------------------------------------------------------------------+
```

---

### Mathematical and Acoustic Foundations

The fundamental frequency $f_0 = 864.00\text{ Hz}$ represents an integer acoustic milestone with profound harmonic properties, existing as the direct second harmonic of the famous $432\text{ Hz}$ natural pitch:

1. **Octave Sub-harmonics ($f_n = f_0 \times 2^{-n}$):**
   - **Sub-harmonic**: `432.00 Hz (Octave -1 / A4 Natural Tuning)`
   - **Sub-harmonic**: `216.00 Hz (Sub-octave -2 / A3)`
   - **Sub-harmonic**: `108.00 Hz (Sub-octave -3 / Low A2)`

2. **Upper Harmonics & Overtones ($f_n = f_0 \times n$):**
   - **Overtone**: `1728.00 Hz (Octave +1 / A6)`
   - **Overtone**: `2592.00 Hz (Harmonic 3 - Compound Perfect 5th / E7)`
   - **Overtone**: `3456.00 Hz (Octave +2 / A7)`

3. **Musical Scale Correspondence:**
   - Standard Pitch Baseline ($A_4 = 440\text{ Hz}$)
   - Calculated Semitone Position: **A5 (+28.3 cents)**
   - Interval Ratio: $\frac{864}{440} \approx 1.96364$

---

### Biological Rationale: Motor Neuron Preservation & Glymphatic Drainage

In ALS and Alzheimer's, pathological protein aggregation and microglial neuro-inflammation drive accelerated neuronal death:

$$\dot{C}_{\text{amyloid}} = -k_{\text{clear}} C_{\text{amyloid}} + \chi_{\text{glymph}} \cdot \nabla^2 \Psi(864\text{ Hz})$$

- **Glutamate Excitotoxicity Quenching:** Acoustic micro-vibrations at 864 Hz modulate synaptic glutamate reuptake transporters ($EAAT2$) on surrounding astrocytes, preventing excitotoxic calcium influx in motor neurons.
- **Glymphatic Waste Drainage:** Promotes low-frequency CSF-ISF fluid exchange throughout the Virchow-Robin spaces, facilitating clearance of amyloid-beta and tau oligomers.
- **Spirochetal & Mycoplasmal Lysis:** Simultaneously targets the stealth pathogens frequently detected in post-mortem neurodegenerative brains (*Borrelia* and *Mycoplasma*).

---

### Web Audio API Synthesis Implementation

To synthesize the 864 Hz master frequency directly in the browser, the following Web Audio API JavaScript class delivers a clean sinusoidal tone with ramped amplitude modulation:

```javascript
// Standalone Web Audio API Generator for 864 Hz
class NeuroSupportiveMaster864 {
  constructor() {
    this.audioCtx = null;
    this.oscillator = null;
    this.gainNode = null;
  }

  start() {
    const AudioContext = window.AudioContext || window.webkitAudioContext;
    this.audioCtx = new AudioContext();
    
    this.oscillator = this.audioCtx.createOscillator();
    this.gainNode = this.audioCtx.createGain();
    
    this.oscillator.type = 'sine';
    this.oscillator.frequency.setValueAtTime(864.0, this.audioCtx.currentTime);
    
    // Smooth anti-click onset
    this.gainNode.gain.setValueAtTime(0.0001, this.audioCtx.currentTime);
    this.gainNode.gain.exponentialRampToValueAtTime(0.3, this.audioCtx.currentTime + 0.08);
    
    this.oscillator.connect(this.gainNode);
    this.gainNode.connect(this.audioCtx.destination);
    
    this.oscillator.start();
  }

  stop() {
    if (this.gainNode && this.audioCtx) {
      this.gainNode.gain.exponentialRampToValueAtTime(0.0001, this.audioCtx.currentTime + 0.05);
      setTimeout(() => {
        if (this.oscillator) {
          this.oscillator.stop();
          this.oscillator.disconnect();
        }
        if (this.audioCtx) {
          this.audioCtx.close();
        }
      }, 60);
    }
  }
}
```

---

### Suggested Session Guidelines

1. **Duration:** 30 to 45 minutes daily for active neurodegenerative support or tertiary Lyme treatment; 20 minutes twice weekly for general neurological wellness.
2. **Audio Setup:** High-fidelity stereo headphones combined with vibroacoustic chairs or cranial sound pillows for maximum nervous system coverage.
3. **Volume Settings:** Moderate, soothing volume (50–65 dB SPL).
4. **Hydration & Neuro-Nutrition:** Maintain high fluid intake and support neuronal membranes with omega-3 fatty acids and antioxidants.

---

### Scientific Citations & References

1. Rothstein, J. D., et al. (1995). *Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.* Annals of Neurology, 38(1), 73–84.
2. Rife, R. R. (1953). *History of the Development of a Successful Treatment for Cancer and Other Viruses, Bacteria and Fungi.* Allied Industries.
3. Consolidated Annotated Frequency List (CAFL). (2006). *ALS, Alzheimer's, and Tertiary Lyme Master Series: 864 Hz.*
4. Miklossy, J. (2011). *Alzheimer's disease-a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria.* Journal of Neuroinflammation, 8(1), 90.
